Abstract
Objectives
. Slowly growing mycobacteria (SGM) are prevalent worldwide and cause an extensive spectrum of diseases.Methods. In this study, the antimicrobial susceptibility of 33 reference strains of SGM to 19 antimicrobial agents was tested using a modified microdilution method.Results. Cefmetazole (32/33) and azithromycin (32/33) exhibited the highest antimicrobial activity, and dapsone (9/33) exhibited the lowest activity against the tested strains. Cefoxitin (30/33), cefoperazone (28/33), and cefepime (28/33) were effective against a high proportion of strains, and macrolides were also highly effective as well as offering the benefit of convenient oral administration to patients. Linezolid (27/33), meropenem (26/33), sulfamethoxazole (26/33), and tigecycline (25/33) showed the highest activity; clofazimine (20/33) and doxycycline (18/33) showed intermediate activity; and rifapentine (13/33), rifabutin (13/33), and minocycline (11/33) showed low antimicrobial activity, closely followed by thioacetazone (10/33) and pasiniazid (10/33), against the tested organisms. According to their susceptibility profiles, the slowly growing speciesMycobacterium aviumandMycobacterium simiaewere the least susceptible to the tested drugs, where...Continue Reading
References
Feb 6, 2007·American Journal of Respiratory and Critical Care Medicine·David E GriffithUNKNOWN Infectious Disease Society of America
Dec 20, 2008·The Journal of Molecular Diagnostics : JMD·Suporn FoongladdaRuengpung Sutthent
Jan 21, 2010·Current Opinion in Infectious Diseases·David E Griffith
Aug 31, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Mateja JankovicVera Katalinic Jankovic
Oct 1, 2011·Future Microbiology·Zoe GittiGeorge Samonis
Mar 29, 2013·Journal of Clinical Microbiology·Richard J WallaceJoseph O Falkinham
May 22, 2013·International Journal of Medical Microbiology : IJMM·Michael HombachErik C Böttger
Oct 24, 2013·BMC Infectious Diseases·Imran AhmedRumina Hasan
Dec 3, 2014·Enfermedades infecciosas y microbiología clínica·Pedro García-MartosManuel Rodríguez-Iglesias
Dec 9, 2014·PloS One·Ali Akbar VelayatiMehdi Mirsaeidi
Feb 7, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S S TangL Y Hsu
Feb 14, 2015·Clinics in Chest Medicine·Julie V Philley, David E Griffith
Jul 5, 2015·The Journal of Antimicrobial Chemotherapy·Beatriz E FerroJohan W Mouton
Jul 16, 2015·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T TsukataniK Matsumoto
Sep 10, 2015·BioMed Research International·Hui PangPing Yu
Oct 16, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Parvin HeidariehAbodolrazagh Hashemi Shahraki
Oct 29, 2015·Tuberculosis and Respiratory Diseases·Suk Hyeon JeongWon-Jung Koh
Jan 3, 2016·The Journal of Infection·S CowmanM R Loebinger
Feb 18, 2016·Antimicrobial Agents and Chemotherapy·Hannelore I BaxJurriaan E M de Steenwinkel
Apr 7, 2016·American Journal of Ophthalmology·Milan ShahHarry W Flynn
May 22, 2016·Applied and Environmental Microbiology·Samuel Yaw AboagyeDorothy Yeboah-Manu
Oct 28, 2016·Microbial Pathogenesis·Davood AzadiAbass Daei Naser
Nov 5, 2016·Diagnostic Microbiology and Infectious Disease·Seong Mi MoonWon-Jung Koh
Citations
May 14, 2020·Journal of Wildlife Diseases·Justice Opare OdoiTetsuo Asai
Feb 24, 2021·Antimicrobial Agents and Chemotherapy·Bettina SchulthessPeter Sander
Jul 7, 2021·Future Microbiology·Rohini Mattoo